BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2936314)

  • 1. Renal involvement follows cardiac enlargement in essential hypertension.
    Kobrin I; Frohlich ED; Ventura HO; Messerli FH
    Arch Intern Med; 1986 Feb; 146(2):272-6. PubMed ID: 2936314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular adaptation to cyclosporine-induced hypertension.
    Ventura HO; Lavie CJ; Messerli FH; Valentino V; Smart FW; Stapleton DD; Ochsner JL
    J Hum Hypertens; 1994 Apr; 8(4):233-7. PubMed ID: 8021902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of hypertension on the renal and cardiac functions of patients with heart transplantation].
    Farge D; Julien J; Amrein C; Guillemain R; Vulser C; Mihaileanu S; Dreyfus G; Couetil JP; Carpentier A
    Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1129-33. PubMed ID: 2148070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General and regional hemodynamics in hypertension in chronic renal disease.
    Brod J; Fencl V; Ulrych M
    Clin Nephrol; 1975 Nov; 4(5):175-82. PubMed ID: 1192619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-1 and cardiac mass in essential hypertension: comparative effects of captopril, lisinopril and quinapril.
    Díez J; Laviades C
    J Hypertens Suppl; 1994 Jul; 12(4):S31-6. PubMed ID: 7965272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular geometry and renal function in hypertensive patients with diastolic heart failure.
    Afshinnia F; Spitalewitz S; Chou SY; Gunsburg DZ; Chadow HL
    Am J Kidney Dis; 2007 Feb; 49(2):227-36. PubMed ID: 17261425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal function and hemodynamic studies in low- and normal-renin essential hypertension.
    Bauer JH; Brooks CS; Burch RN
    Arch Intern Med; 1982 Jul; 142(7):1317-23. PubMed ID: 7046671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The pattern of left ventricular hypertrophy in hypertension and its relation to the hemodynamic and sympathetic responses to exercise].
    Arita M; Ueno Y; Fujiwara S; Hamada M; Hano T; Nishio I; Masuyama Y
    J Cardiogr; 1986 Mar; 16(1):95-104. PubMed ID: 2946785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in left ventricular anatomy and systemic hemodynamics induced by antihypertensive therapy with indenolol.
    De Luca N; Ricciardelli B; Groothold G; Cuocolo A; Volpe M; Trimarco B
    J Clin Hypertens; 1987 Jun; 3(2):125-34. PubMed ID: 2956371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Left ventricular hypertrophy in hypertension: functional aspects].
    Lombardo M; Zaini G; Colloca W; Belli C
    G Ital Cardiol; 1987 Dec; 17(12):1039-44. PubMed ID: 2972580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular hypertrophy regression in hypertensive patients treated with metoprolol.
    Corea L; Bentivoglio M; Verdecchia P; Provvidenza M; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):365-70. PubMed ID: 6236155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Troponin I serum concentration: a new marker of left ventricular hypertrophy in patients with essential hypertension.
    Siciliano M; Mettimano M; Dondolini-Poli A; Ballarin S; Migneco A; Annese R; Fazzari L; Fedeli P; Montebelli MR; Zuppi C; Savi L
    Ital Heart J; 2000 Aug; 1(8):532-5. PubMed ID: 10994933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association between blood pressure and circulating hormonal factors with left ventricular mass in patients with essential hypertension older than 55 years of age].
    González Quijada S; Luque Otero M; Fernández-Cruz A; Almería C; Bagazgoitia Barrera J; Moya Marín FJ
    Med Clin (Barc); 1997 Oct; 109(12):441-4. PubMed ID: 9441177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertensive renal vascular disease and cardiovascular endpoints.
    Matavelli LC; Zhou X; Frohlich ED
    Curr Opin Cardiol; 2006 Jul; 21(4):305-9. PubMed ID: 16755198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal haemodynamic studies in obesity hypertension.
    Reisin E; Messerli FG; Ventura HO; Frohlich ED
    J Hypertens; 1987 Aug; 5(4):397-400. PubMed ID: 3668243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Uric acid and arterial hypertension. IV. Relation between serum uric acid level, the extent of vascular changes and heart enlargement in primary arterial hypertension].
    Tykarski A; Oko-Sarnowska Z; Skołuda A
    Pol Arch Med Wewn; 1991 Sep; 86(3):183-8. PubMed ID: 1839699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension, renal function and gout.
    Gibson T; Highton J; Simmonds HA; Potter CF
    Postgrad Med J; 1979; 55 Suppl 3():21-5. PubMed ID: 504036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glomerular hyperfiltration indicates early target organ damage in essential hypertension.
    Schmieder RE; Messerli FH; Garavaglia G; Nunez B
    JAMA; 1990 Dec; 264(21):2775-80. PubMed ID: 2146412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum uric acid in essential hypertension: an indicator of renal vascular involvement.
    Messerli FH; Frohlich ED; Dreslinski GR; Suarez DH; Aristimuno GG
    Ann Intern Med; 1980 Dec; 93(6):817-21. PubMed ID: 7447188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential hypertension in the elderly: haemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels.
    Messerli FH; Sundgaard-Riise K; Ventura HO; Dunn FG; Glade LB; Frohlich ED
    Lancet; 1983 Oct; 2(8357):983-6. PubMed ID: 6138591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.